LGALS3 and breast cancer: The JIMT-1 breast cancer cell line was chosen for the remaining experiments due its growth pattern (i.e. the cells do not grow tightly together in patches or on top of each other) and due to the relatively flat morphology of the cells, making galectin-3 puncta easier to quantify.